Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Ezekowitz

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
European Journal of Heart Failure|October 16, 2025
Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosisLucia Venneri, Alberto Aimo, Aldostefano Porcari, et al.
Heart Rhythm|February 7, 2025
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failureIlan Goldenberg, Justin Ezekowitz, Christine Albert, et al.
The Canadian Journal of Cardiology|August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in AdultsG B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
CJC Open|December 22, 2025
The Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Trial-IMAGE HF Project 1ALisa M Mielniczuk, Eileen O'Meara, Christiane Wiefels, et al.
Nature Medicine|August 27, 2023
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trialBarry A Borlaug, Dalane W Kitzman, Melanie J Davies, et al.
The New England Journal of Medicine|August 25, 2023
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and ObesityMikhail N Kosiborod, Steen Z Abildstrøm, Barry A Borlaug, et al.
European Heart Journal|June 5, 2020
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Stefan D Anker, Javed Butler, Muhammad Shahzeb Khan, et al.
European Heart Journal|July 28, 2022
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trialJaved Butler, Stefan D Anker, Lars H Lund, et al.
JAMA|April 11, 2023
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial, Patrick R Lawler, Lennie P G Derde, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
European Journal of Heart Failure|October 16, 2025
Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosisLucia Venneri, Alberto Aimo, Aldostefano Porcari, et al.
Heart Rhythm|February 7, 2025
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failureIlan Goldenberg, Justin Ezekowitz, Christine Albert, et al.
The Canadian Journal of Cardiology|August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in AdultsG B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
CJC Open|December 22, 2025
The Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Trial-IMAGE HF Project 1ALisa M Mielniczuk, Eileen O'Meara, Christiane Wiefels, et al.
Nature Medicine|August 27, 2023
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trialBarry A Borlaug, Dalane W Kitzman, Melanie J Davies, et al.
The New England Journal of Medicine|August 25, 2023
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and ObesityMikhail N Kosiborod, Steen Z Abildstrøm, Barry A Borlaug, et al.
European Heart Journal|June 5, 2020
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Stefan D Anker, Javed Butler, Muhammad Shahzeb Khan, et al.
European Heart Journal|July 28, 2022
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trialJaved Butler, Stefan D Anker, Lars H Lund, et al.
JAMA|April 11, 2023
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial, Patrick R Lawler, Lennie P G Derde, et al.
Pageof 11